Miguel R. Ossandon, Ph.D.

Miguel R. Ossandon has a dual background in clinical laboratory and computer science. He started working in cancer research at the Lombardi Cancer Center at Georgetown University, where he also began his undergraduate training in computer science. He began working for the National Cancer Institute since 2007. 

Miguel received his master’s degree at The George Washington University and his Ph.D. in computer science at the University of Maryland, Baltimore County. 

As a Program Director in the Diagnostic Biomarkers and Technology Branch, he manages a grant portfolio related to computational modeling and machine learning approaches for cancer diagnosis, digital image processing/analysis, microfluidic and circulating tumor cell technology.

Selected Publications

• Makhlouf HR, Ossandon MR, Farahani K, Lubensky I, Harris LN. Digital pathology imaging artificial intelligence in cancer research and clinical trials: An NCI workshop report. J Pathol Inform. 2025 Nov 14;20:100531. doi: 10.1016/j.jpi.2025.100531
• Pearlman PC, Divi R, Huppi R, Garton E, Kidambi S, Tandon P, Ossandon M, Ginsburg O, Gopal S. First Decade of the National Cancer Institute's Affordable Cancer Technologies Program: Accelerating Translational Technology Research and Development for Cancer Globally. JCO Glob Oncol. 2025 Jul;11:e2500200. doi: 10.1200/GO-25-00200.
• Ossandon MR, Sorg BS, Phatak DS, Kalpakis K. Evaluation of Tumor Development Using Hemoglobin Saturation Profile on Rodent Dorsal Window Chamber. Methods Mol Biol. 2022;2393:179-206. doi:10.1007/978-1-0716-1803-5_10
• Ossandon MR, Agrawal L, Bernhard EJ, et al. Circulating Tumor DNA Assays in Clinical Cancer Research. J Natl Cancer Inst. 2018;110(9):929-934. doi:10.1093/jnci/djy105
• Cancer Detection and Diagnosis A Handbook of Emerging Technologies. Miguel Ossandon, Ben Prickril, Avraham Rasooly, CRC Press 2026
• Biomedical Engineering Technologies Volume 1. Miguel R. Ossandon, Houston Baker, Avraham Rasooly. Springer Nature 2022